Primary Cells

Human Aortic Endothelial Cells-Diabetic Type I

  • For research use only

Cat No.

ABC-TC3495

Product Type

Vascular Cells

Cell Type

Endothelial

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Aorta

Disease

Normal

Storage

Liquid Nitrogen

Human Aortic Endothelial Cells-Diabetic Type I ,Primary endothelial cells from diabetic type I donors; model for vascular biology and metabolic disease.

Product Image

Description

Human Aortic Endothelial Cells-Diabetic Type I are primary cells isolated from the descending aorta (arch to the renal artery) of confirmed Type 1 diabetic human donors. Following primary culture, these cells are cryopreserved. These cells, as the key cellular component of the human aortic endothelium, exhibit characteristic cobblestone morphology. These cells regulate vascular tone and barrier integrity but exhibit hallmark diabetic hyperglycemia-induced dysfunction including impaired nitric oxide synthesis, elevated ROS production, and sustained RAGE/NF-κB-mediated inflammation. These cells have been identified as critical contributors to diabetic vasculopathy, including accelerated atherosclerosis, aortic calcification, hypertension, and microvascular complications like nephropathy and retinopathy. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Aortic Endothelial Cells Type I Diabetes, HAoECs T1DM, Aortic Endothelial Cells Diabetic Type I, Human Aorta ECs T1DM, Diabetic Type I Aortic ECs

Species

Human

Cat.No

ABC-TC3495

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Endothelial

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Aorta

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Vascular Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Aortic Endothelial Cells-Diabetic Type I serve as a pathophysiologically relevant in vitro model to study diabetic vasculopathy in conditions like accelerated atherosclerosis and microangiopathy. Their disease-specific responsiveness enables detailed study of RAGE/NF-κB signaling pathways, particularly in hyperglycemia-induced ICAM-1 upregulation and monocyte adhesion. Researchers can utilize this model to screen advanced glycation end-product (AGE) inhibitors, evaluate NO-boosting therapies targeting plaque progression and develop targeted interventions for diabetic plaque progression and microvascular complications affecting renal and retinal tissues. The cells serve as a crucial translational bridge between basic diabetic vascular research and therapeutic development.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Aortic Endothelial Cells-Diabetic Type I

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button